Combining exome sequencing and functional studies to identify causal genes of ultra-rare neurodevelopmental disorders

[eng] Neurodevelopmental disorders (NDDs) are a group of chronic diseases in which the development of the central nervous system is impaired, resulting in disability at the neuropsychiatric, motor and/or intellectual level. Some of these disorders are considered syndromic. For instance, intellectual...

Descripción completa

Detalles Bibliográficos
Autor: Castilla-Vallmanya, Laura
Tipo de recurso: tesis doctoral
Estado:Versión publicada
Fecha de publicación:2021
País:España
Institución:Universidad de Barcelona
Repositorio:Dipòsit Digital de la UB
OAI Identifier:oai:diposit.ub.edu:2445/186056
Acceso en línea:https://hdl.handle.net/2445/186056
http://hdl.handle.net/10803/674338
Access Level:acceso abierto
Palabra clave:Genètica molecular humana
Neurobiologia del desenvolupament
Malalties rares
Diagnòstic
Human molecular genetics
Developmental neurobiology
Rare diseases
Diagnosis
id ES_4e80b16e88d746211e0f63c69e9ff9e7
oai_identifier_str oai:diposit.ub.edu:2445/186056
network_acronym_str ES
network_name_str España
repository_id_str
spelling Combining exome sequencing and functional studies to identify causal genes of ultra-rare neurodevelopmental disordersCastilla-Vallmanya, LauraGenètica molecular humanaNeurobiologia del desenvolupamentMalalties raresDiagnòsticHuman molecular geneticsDevelopmental neurobiologyRare diseasesDiagnosis[eng] Neurodevelopmental disorders (NDDs) are a group of chronic diseases in which the development of the central nervous system is impaired, resulting in disability at the neuropsychiatric, motor and/or intellectual level. Some of these disorders are considered syndromic. For instance, intellectual disability (ID) may present comorbidity with other neurological conditions (such as seizures or behavioral problems), dysmorphic features and/or internal organ anomalies. The vast majority of syndromic NDDs have a genetic origin and are considered to be rare, affecting less than 1 in 2000 people. However, globally, these diseases represent a serious social and health issue. Even though the majority of them are monogenic, many of them remain with an unknown molecular basis. Next-generation sequencing technologies have played a critical role in the optimization of the diagnosis of NDDs during the last decades. In this thesis, we have used a combination of whole-exome sequencing (WES) and functional studies to establish the diagnosis of 9 cases tentatively diagnosed as Opitz C, a clinical entity that encompasses patients with very different molecular causes. We identified the genetic origin of the disorder in the 7 tested families, which happened to be different variants in different genes for each of them. We showed that WES is a powerful approach to identify the molecular basis of ultra-rare NDDs. A significantly higher diagnosis yield was reached compared with other studies, potentially explained by a deep analysis of the sequencing data using in silico predictors, followed by the performance of specific functional studies for each case. We identified four different variants putatively affecting splicing patterns of different genes (ASXL1, KAT6A, PIGT and FOXP1) and tested them directly using fibroblasts obtained from patients or indirectly using a mini-gene splicing assay. We assessed the effect of variants in DPH1 in protein function combining a biochemical technique with a protein structural model and we established a correlation between the results of the tests and the severity of the patients’ phenotype. We contributed to the delineation of a recently described syndrome caused by germline mutations in TRAF7 by gathering and describing a cohort of 45 patients. We also performed a transcriptomics analysis on fibroblasts from different patients carrying TRAF7 mutations, which showed alterations in the expression of different genes that might contribute to the phenotype. Aiming to characterize truncating mutations in MAGEL2, which are responsible for Schaaf-Yang syndrome (SYS), we performed different experiments that suggest a potential toxic effect of the produced truncated form of the protein, which lacks its most relevant functional domain. Finally, as a first step to establish a relevant in vitro model of SYS, we reprogrammed fibroblasts from different patients to induced pluripotent stem cells (iPSCs), which can be then differentiated to relevant neural cell types and brain organoids to further study the pathophysiological mechanisms underlying this disease.Universitat de BarcelonaBalcells Comas, SusanaUrreizti, RoserUniversitat de Barcelona. Departament de Genètica, Microbiologia i Estadística2021info:eu-repo/semantics/doctoralThesisinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://hdl.handle.net/2445/186056http://hdl.handle.net/10803/674338Tesis Doctorals - Departament - Genètica, Microbiologia i Estadísticareponame:Dipòsit Digital de la UBinstname:Universidad de BarcelonaIngléscc by-nc-sa (c) Castilla-Vilamanya, Laura, 2022http://creativecommons.org/licenses/by-nc-sa/3.0/es/info:eu-repo/semantics/openAccessoai:diposit.ub.edu:2445/1860562026-05-27T06:46:51Z
dc.title.none.fl_str_mv Combining exome sequencing and functional studies to identify causal genes of ultra-rare neurodevelopmental disorders
title Combining exome sequencing and functional studies to identify causal genes of ultra-rare neurodevelopmental disorders
spellingShingle Combining exome sequencing and functional studies to identify causal genes of ultra-rare neurodevelopmental disorders
Castilla-Vallmanya, Laura
Genètica molecular humana
Neurobiologia del desenvolupament
Malalties rares
Diagnòstic
Human molecular genetics
Developmental neurobiology
Rare diseases
Diagnosis
title_short Combining exome sequencing and functional studies to identify causal genes of ultra-rare neurodevelopmental disorders
title_full Combining exome sequencing and functional studies to identify causal genes of ultra-rare neurodevelopmental disorders
title_fullStr Combining exome sequencing and functional studies to identify causal genes of ultra-rare neurodevelopmental disorders
title_full_unstemmed Combining exome sequencing and functional studies to identify causal genes of ultra-rare neurodevelopmental disorders
title_sort Combining exome sequencing and functional studies to identify causal genes of ultra-rare neurodevelopmental disorders
dc.creator.none.fl_str_mv Castilla-Vallmanya, Laura
author Castilla-Vallmanya, Laura
author_facet Castilla-Vallmanya, Laura
author_role author
dc.contributor.none.fl_str_mv Balcells Comas, Susana
Urreizti, Roser
Universitat de Barcelona. Departament de Genètica, Microbiologia i Estadística
dc.subject.none.fl_str_mv Genètica molecular humana
Neurobiologia del desenvolupament
Malalties rares
Diagnòstic
Human molecular genetics
Developmental neurobiology
Rare diseases
Diagnosis
topic Genètica molecular humana
Neurobiologia del desenvolupament
Malalties rares
Diagnòstic
Human molecular genetics
Developmental neurobiology
Rare diseases
Diagnosis
description [eng] Neurodevelopmental disorders (NDDs) are a group of chronic diseases in which the development of the central nervous system is impaired, resulting in disability at the neuropsychiatric, motor and/or intellectual level. Some of these disorders are considered syndromic. For instance, intellectual disability (ID) may present comorbidity with other neurological conditions (such as seizures or behavioral problems), dysmorphic features and/or internal organ anomalies. The vast majority of syndromic NDDs have a genetic origin and are considered to be rare, affecting less than 1 in 2000 people. However, globally, these diseases represent a serious social and health issue. Even though the majority of them are monogenic, many of them remain with an unknown molecular basis. Next-generation sequencing technologies have played a critical role in the optimization of the diagnosis of NDDs during the last decades. In this thesis, we have used a combination of whole-exome sequencing (WES) and functional studies to establish the diagnosis of 9 cases tentatively diagnosed as Opitz C, a clinical entity that encompasses patients with very different molecular causes. We identified the genetic origin of the disorder in the 7 tested families, which happened to be different variants in different genes for each of them. We showed that WES is a powerful approach to identify the molecular basis of ultra-rare NDDs. A significantly higher diagnosis yield was reached compared with other studies, potentially explained by a deep analysis of the sequencing data using in silico predictors, followed by the performance of specific functional studies for each case. We identified four different variants putatively affecting splicing patterns of different genes (ASXL1, KAT6A, PIGT and FOXP1) and tested them directly using fibroblasts obtained from patients or indirectly using a mini-gene splicing assay. We assessed the effect of variants in DPH1 in protein function combining a biochemical technique with a protein structural model and we established a correlation between the results of the tests and the severity of the patients’ phenotype. We contributed to the delineation of a recently described syndrome caused by germline mutations in TRAF7 by gathering and describing a cohort of 45 patients. We also performed a transcriptomics analysis on fibroblasts from different patients carrying TRAF7 mutations, which showed alterations in the expression of different genes that might contribute to the phenotype. Aiming to characterize truncating mutations in MAGEL2, which are responsible for Schaaf-Yang syndrome (SYS), we performed different experiments that suggest a potential toxic effect of the produced truncated form of the protein, which lacks its most relevant functional domain. Finally, as a first step to establish a relevant in vitro model of SYS, we reprogrammed fibroblasts from different patients to induced pluripotent stem cells (iPSCs), which can be then differentiated to relevant neural cell types and brain organoids to further study the pathophysiological mechanisms underlying this disease.
publishDate 2021
dc.date.none.fl_str_mv 2021
dc.type.none.fl_str_mv info:eu-repo/semantics/doctoralThesis
info:eu-repo/semantics/publishedVersion
format doctoralThesis
status_str publishedVersion
dc.identifier.none.fl_str_mv https://hdl.handle.net/2445/186056
http://hdl.handle.net/10803/674338
url https://hdl.handle.net/2445/186056
http://hdl.handle.net/10803/674338
dc.language.none.fl_str_mv Inglés
language_invalid_str_mv Inglés
dc.rights.none.fl_str_mv cc by-nc-sa (c) Castilla-Vilamanya, Laura, 2022
http://creativecommons.org/licenses/by-nc-sa/3.0/es/
info:eu-repo/semantics/openAccess
rights_invalid_str_mv cc by-nc-sa (c) Castilla-Vilamanya, Laura, 2022
http://creativecommons.org/licenses/by-nc-sa/3.0/es/
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Universitat de Barcelona
publisher.none.fl_str_mv Universitat de Barcelona
dc.source.none.fl_str_mv Tesis Doctorals - Departament - Genètica, Microbiologia i Estadística
reponame:Dipòsit Digital de la UB
instname:Universidad de Barcelona
instname_str Universidad de Barcelona
reponame_str Dipòsit Digital de la UB
collection Dipòsit Digital de la UB
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1869407760534208512
score 15,300719

Similares en LA Referencia